We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

New Study Confirms COVID-19 Vaccine Will Need to Elicit T Cells to Work alongside Antibodies

By HospiMedica International staff writers
Posted on 03 Jul 2020
Print article
Image: Dr. Alessandro Sette and Dr. Daniela Weiskopf (Photo curtesy of La Jolla Institute for Immunology)
Image: Dr. Alessandro Sette and Dr. Daniela Weiskopf (Photo curtesy of La Jolla Institute for Immunology)
A new study has shown that even the sickest COVID-19 patients produce T cells that help fight the virus, thus offering further evidence that a COVID-19 vaccine will need to elicit T cells to work alongside antibodies.

The study conducted by researchers at La Jolla Institute for Immunology (LJI La Jolla, CA, USA) and Erasmus University Medical Center (Rotterdam, Netherlands) also revealed that both Dutch and American patients have similar responses to the virus. For the study, the researchers followed 10 COVID-19 patients with the most severe disease symptoms who were put on ventilators out of which two patients eventually died of the disease. An in-depth look at their immune system responses showed that all the 10 patients produced T cells that targeted the SARS-CoV-2 virus. These T cells worked alongside antibodies to try to clear the virus and stop the infection.

These findings are in line with a recent study that showed a robust T cell response in individuals with moderate cases of COVID-19. In both the studies, the T cells in these patients prominently targeted the “spike” protein on SARS-CoV-2. The virus uses the spike protein to enter host cells, and most vaccine efforts around the world are aimed at getting the immune system to recognize and attack this protein. The new study offers further evidence that the spike protein is a promising target and confirms that the immune system can also mount strong responses to other targets on the virus.

“This is key to understanding how the immune response fights the virus,” said LJI Professor Alessandro Sette, Dr. Biol. Sci., who co-led the study with Erasmus MC Virologist Rory de Vries, Ph.D. “You want vaccine approaches to be grounded in observations from rather diverse settings to ensure that the results are generally applicable.”

“Activating these cells appears to be at least as important as the production of antibodies,” says Erasmus MC Virologist Rory de Vries, Ph.D., who co-led the study with Sette.

Related Links:
La Jolla Institute for Immunology
Erasmus University Medical Center


Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
12-Channel ECG
CM1200B
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Remote Controlled Digital Radiography and Fluoroscopy System
Eco Track-DRF - MARS 50/MARS50+/MARS 65/MARS 80

Print article

Channels

Critical Care

view channel
Image: The stretchable microneedle electrode arrays (Photo courtesy of Zhao Research Group)

Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment

The field of personalized medicine is transforming rapidly, with advancements like wearable devices and home testing kits making it increasingly easy to monitor a wide range of health metrics, from heart... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more